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INTRODUCTION:  Gallstones  are  a common  condition  in  bariatric  patients  after a laparoscopic  Roux-en-Y
gastric  bypass  (LRYGB).  The  management  of  ductal  stones  is  challenging  due  to  the altered  gastrointestinal
anatomy.  Various  techniques  have  been  reported  to manage  bile  duct  stones.
PRESENTATION  OF  CASE:  We  present  the successful  percutaneous  trans  hepatic  management  of  common
bile duct  stones  after  LRYGB.
One  year  after  a LRYGB  for morbid  obesity,  a  59-year-old  female  presented  with  acute  cholecystitis.
One  month  after  laparoscopic  cholecystectomy  a 1 cm calculus  was  found  within  the  distal  CBD  and
patient  underwent  a percutaneous  trans hepatic  cholangiography  under  local  anesthetic.  This  involved
a  right  sided  anterior  segmental  duct  puncture.  With  the  sphincter  dilated  to 10  mm,  a balloon  catheter
was used  to push  the stone  into  the duodenum  leaving  an  internal-  external  drain.  Patient  recovered
completely  at follow  up.
DISCUSSION:  Patients  with  morbid  obesity  have  a higher  incidence  of gallstones.  After  LRYGB,  the altered
anatomy  does  not  allow  the conventional  endoscopic  retrograde  cholangiopancreatography  (ERCP)  for
choledocholithiasis.
Various techniques  have been  reported  as  means  of  managing  bile  duct  stones  in  LRYGB  patients.
These  include  a double  balloon  enteroscope-assisted  ERCP,  laparoscopic  transgastric  ERCP,  laparoscopic
or  open  biliary  surgery  and  interventional  radiology.  We  report a non-surgical  approach  using  percuta-
neous  transhepatic  technique  under  local  anesthetic  that  resulted  effective  and  could be  applied  more
extensively.
CONCLUSION:  Due  to the  increase  of  global  obesity,  bariatric  centers  need  to strategically  plan  resources
such  as  interventional  radiology  in  order to manage  post  LRYGB  choledocholithiasis  safely,  efﬁciently
and  in a  cost  effective  manner.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Gallstones are a common condition in bariatric patients after a
aparoscopic Roux-en-Y gastric bypass (LRYGB). The management
f ductal stones in these patients is also challenging due to the
ltered gastrointestinal anatomy. The Roux-en-Y reconstruction
akes the conventional endoscopic retrograde cholangiopancre-
tography (ERCP) for choledocholithiasis difﬁcult in such patients
Fig. 1). Various techniques have been proposed to treat bile
uct stones in LRYGB patients. These include a double balloon
nteroscope-assisted ERCP using direct cholangioscopy with the
∗ Corresponding author at: Chelsea and Westminster NHS Foundation Trust, 369
ulham Road, London, SW10 9NH, United Kingdom. Tel.: +44 0203 315 8463;
ax: +44 0203 315 8282.
E-mail address: Gianluca.Bonanomi@chelwest.nhs.uk (G. Bonanomi).
ttp://dx.doi.org/10.1016/j.ijscr.2014.03.003
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
aid of a gastroscope to perform a sphincterotomy in patients after a
Roux-en-Y and a Billroth II gastrojejunostomy. Laparoscopic trans-
gastric ERCP is another option for treating biliary tract disease in
LRYGB patients. This involves a combined surgical and endoscopic
procedure under general anesthetic. A gastrostomy is performed
through the anterior wall of the greater curve of the excluded stom-
ach with the introduction of a duodenoscope to perform the ERCP
and a sphincterotomy. Laparoscopic or open biliary surgery and
interventional radiology have been also reported.
2. Presentation of caseWe present the successful percutaneous trans hepatic (PTC)
management of common bile duct retained stones after laparo-
scopic cholecystectomy in a patient who had a previous LRYGB.
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 2. The initial cholangiogram with an inset image of the MRCP showing the
six weeks later.Fig. 1. Roux en Y gastric bypass – Anatomy.
A 59-year-old female presented as an emergency with right
pper quadrant pain and vomiting. She had a LRYGB for mor-
id obesity with a body mass index (BMI) of 44.5 kg/m2 a year
efore. Her BMI  at the time of admission was 30.9 kg/m2, with
n excess weight loss of 62%. Her past medical history included
sthma, depression and a total abdominal hysterectomy. Blood
ests showed a bilirubin of 8 (0–21) mol/l, alkaline phosphatase
ALP) of 221 (30–130) iu/l and an alanine transaminase (ALT) of
99 (0–40) iu/l. An ultrasound scan performed at the time showed
n acute cholecystitis and fatty inﬁltration of the liver. There was
o evidence of intra or extrahepatic biliary tree dilatation and no
uctal stones were demonstrated. She was discharged on antibi-
tic treatment and liver function tests normalized in the following
eeks. An MRCP demonstrated several small gallstones with no
vidence of intra or extrahepatic biliary tree dilatation or ductal
tones. The acute symptoms resolved in a few days and 4 weeks
ater an elective laparoscopic cholecystectomy was  performed with
n uneventful post-operative period.
The patient presented a month later complaining of epigastric
ain radiating to the back and localized peritonism. Her bilirubin
as 66 mol/l, ALT 437 iu/l, ALP 849 iu/l and a normal amylase. An
nitial CT scan did not show any evidence of a perforation or col-
ection. An MRCP showed mild intrahepatic duct dilatation, with a
ommon bile duct (CBD) of 1 cm and a calculus within the distal
BD. She underwent a percutaneous trans hepatic cholangiogram
PTC) under local anesthetic (Fig. 2) through a right-sided anterior
egmental duct puncture. The sphincter was dilated to 10 mm with
 balloon catheter which was then used to push the stone into the
uodenum leaving an 8-French internal-external drain. The patient
linically improved within a few hours with normally functioninglocation of the stone in the bile duct (white arrow).
drainage. After 24 h, contrast was injected through the drain, show-
ing no ﬁlling defects to suggest retained stones, and normal passage
into the duodenum (Fig. 3). The drain was therefore withdrawn into
the distal CBD and a repeat cholangiogram performed, which again
showed no evidence of choledocolithiasis, demonstrating excellent
drainage of the biliary tree and the internal-external drain was then
removed on the same day. There was no bleeding or signiﬁcant
bile leak from the tract. The patient was discharged home after 2
days with improving liver function tests (bilirubin 35 mol/l, ALT
121 iu/l, ALP 436 iu/l) and she recovered completely at follow-upFig. 3. Cholangiogram following injection of contrast through the pigtail drain
showing no ﬁlling defects to suggest retained stones.
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. Discussion
Patients with morbid obesity have a higher incidence of gall-
tones compared to the general population, up to 50% as reported
n the literature.1,2 Formation of gallstones after rapid weight-
oss is also a well-recognised phenomenon. Due to the rapid
eight loss, the ﬁrst year after LRYGB predisposes patients to the
ccurrence of gallstones.3 The mechanisms associated with gall-
tone formation include cholesterol supersaturation of the bile,
ncreased mucin secretion and reduced gall bladder motility due to
agal nerve injury.4 There are no standard therapies after bariatric
urgery we employ at our institution. We  tend to treat patients
ith symptomatic gallstones on an individual basis by carrying
ut a laparoscopic cholecystectomy. We  support the position that
 laparoscopic cholecystectomy at the time of gastric bypass is
ot necessary in asymptomatic cholelythiasis. As demonstrated by
arschkow R in a recent meta-analysis,5 a prophylactic concomi-
ant cholecystectomy during LRYGB should be avoided in patients
ithout gallstones and exclusively be performed in patients with
ymptomatic biliary disease. Also, a 6-month prophylactic regimen
f ursodiol, which is adopted by one third of bariatric surgeons, is
ot recommended because of the additional costs,6 patient com-
liance and the relative small reduction of cholecystectomy rates.7
s reported by Caruana JA in 2005,8 most newly formed gallstones
fter gastric bypass are likely asymptomatic, prophylactic chole-
ystectomy is not indicated, and ursodiol therapy may  be better
eserved for symptomatic patients who refuse cholecystectomy.
rior to the laparoscopic cholecystectomy the patient underwent
n MRCP that did not show evidence of ductal stones and the liver
unction tests returned within normal limits, hence a combined
rocedure for stone clearance was not indicated. An on-table-
holangiogram could have identiﬁed the CBD stones but we do
ot routinely perform the investigation at our institution without
linical evidence.
The management of CBD stones after LRYGB makes the conven-
ional endoscopic retrograde cholangiopancreatography (ERCP) for
holedocholithiasis difﬁcult, due to the exclusion of the duodenum
rom the gastrointestinal tract and the long anatomic route from
outh to the major papilla. The Roux limb is at least 100 cm in
ength (Fig. 1). Several techniques have been proposed to treat bile
uct stones in LRYGB patients.
In 1998 Baron and Vickers described the creation of a sur-
ical gastrostomy to access the gastric remnant. This technique
equires the initial placement of a surgical gastrostomy in the
xcluded stomach and ERCP is then performed through the gas-
rostomy tract.9 Later, double balloon was introduced as a new
ndoscopic technique that allowed examination of the entire small
owel.10 Comparing ERCP via gastrostomy (GERCP) and double bal-
oon enteroscopy (DBERCP), it has been shown that GERCP is more
ffective than DBERCP in gaining access to the pancreatobiliary tree
n patients with RYGB, but it is hindered by gastrostomy maturation
elay and higher morbidity.11–13
In a recent report14 the performance of percutaneous endo-
copic gastrostomy (PEG) with immediate self-expandable metal
tent (SEMS) placement allows antegrade transgastric ERCP dur-
ng the same procedure. With the use of balloon assisted
nteroscopy, retrograde PEG/SEMS in excluded stomach allows
herapeutic ERCP without need for surgery. Also, in a retro-
pective study, Schreiner showed laparoscopy assisted ERCP had
etter outcomes compared with balloon enteroscopy assisted
RCP in LRYGB patients where the Roux limb and biliopancreatic
s 150 cm or longer. In patients with less than 150 cm,  bal-
oon enteroscopy assisted ERCP should be considered ﬁrst line if
vailable.15
According to Martinez an antegrade biliary stenting follow-
ng laparoscopic common bile duct exploration for cholelithiasisPEN  ACCESS
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and associated common bile duct stones is an effective and safe
technique.16
Percutaneous trans hepatic cholangioscopic lithotomy (PTCSL),
which was introduced to treat hepatolithiasis in 1981 by Nimura,17
can be an alternative option for this condition.18 The procedure
is also a useful alternative therapy for conditions such as compli-
cated retained stones, biliary stones in poor surgical candidates,
and altered anatomy in patients who have received a gastrectomy.
PTCSL is a technically easy and useful treatment for removal of
CBD stones because of its easy approach and direct visualization
of bile duct stones. However, this procedure has been generally
restricted to cases in which conventional endoscopic procedures
were unmanageable or unsuccessful. Additionally, it is generally
safe and well tolerated despite long procedure time, especially in
elderly or in patients in poor conditions. A success rate of 100%
with complete stone removal and only minor and transient com-
plications has been reported.18
We have adopted the percutaneous trans hepatic approach with
papillary balloon dilatation proposed by Nagashima19 which could
be considered the ﬁrst choice in patients with altered anatomy
such as having diverticuli near the papilla and following a Billroth
II gastrectomy or LRYGB.
One of the main advantages of this procedure is it can be per-
formed under local anaestethic allowing successful clearance of the
CBD with the expertise of an interventional radiologist, minimizing
costs and avoiding more invasive procedures.
In a large series of 261 patients treated with PTC a complication
rate of 6.8% with no mortality has been reported. Major compli-
cations included cholangitis (2.7%), subcapsular bilioma (1.5/%),
bile peritonitis (0.38%), CBD or duodenal perforation (0.38%), liver
abscess (0.38%), subcapsular hematoma (0.38%) and artery transec-
tion (0.38%).20 Only one patient required surgical treatment due to
duodenal perforation.20
In our experience, this percutaneous approach to manage CBD
stones after LRYGB resulted safe and effective with no need for fur-
ther endoscopic or surgical procedures. There is no speciﬁc limit
to the number of stones to be extracted, however multiple stones
could decrease the likelihood of complete clearance. Larger stones
may  be more difﬁcult to push through the ampulla considering that
a sphincterotomy cannot be achieved, but a balloon sphinteroplasty
up to 14 mm (according to the stone and the CBD diameter) can be
safely performed, preserving a normal papillary function. The same
technique could also be successfully used if a concomitant biliary
stricture is found.21
Transhepatic holmium laser lithotripsy could be another safe
and effective way  to clear large solitary or impacted CBD stones,18,22
but it has not yet a widespread use. We  do not have the laser facil-
ities at our institution, therefore, if the obstructed stone could not
have been advanced or removed during the percutaneous tran-
shepatic approach, our strategy would have been to perform a
laparoscopy assisted ERCP.
4. Conclusion
The obesity epidemic and the high prevalence of obesity related
comorbidities, represent a worldwide public health problem.9
Surgical treatment of obesity is the most effective mean of
weight loss in this patient population. Among all bariatric oper-
ation LRYGB is considered the gold standard. As a consequence,
clinicians encounter an increasing number of pancreatobiliary
pathology (e.g. choledocholithiasis) requiring ERCP within a Roux-
en-Y anatomy.19 With the increase in global obesity, the need for
bariatric surgery will be exponentially augmented, therefore the
problem of biliary pathology is likely to increase as well. Bariatric
centers therefore need to strategically plan resources such as
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nterventional radiology in order to manage such problems safely,
fﬁciently and in a cost effective manner.
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